Logo image of RMB.CA

RUMBU HOLDINGS LTD (RMB.CA) Stock Fundamental Analysis

TSX-V:RMB - TSX Venture Exchange - CA7813911079 - Common Stock - Currency: CAD

0.4  -0.1 (-20%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to RMB. RMB was compared to 0 industry peers in the Unkown industry. RMB may be in some trouble as it scores bad on both profitability and health. RMB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RMB had negative earnings in the past year.
In the past year RMB had a positive cash flow from operations.
RMB.CA Yearly Net Income VS EBIT VS OCF VS FCFRMB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA -20.23%
ROE -179.57%
ROIC 2.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RMB.CA Yearly ROA, ROE, ROICRMB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 -100 -200 -300 -400

1.3 Margins

Industry RankSector Rank
OM 8.02%
PM (TTM) N/A
GM 74.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RMB.CA Yearly Profit, Operating, Gross MarginsRMB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RMB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RMB has about the same amount of shares outstanding.
There is no outstanding debt for RMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RMB.CA Yearly Shares OutstandingRMB.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M
RMB.CA Yearly Total Debt VS Total AssetsRMB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 100K 200K 300K

2.2 Solvency

RMB has an Altman-Z score of 0.81. This is a bad value and indicates that RMB is not financially healthy and even has some risk of bankruptcy.
RMB has a debt to FCF ratio of 38.65. This is a negative value and a sign of low solvency as RMB would need 38.65 years to pay back of all of its debts.
RMB has a Debt/Equity ratio of 5.67. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 5.67
Debt/FCF 38.65
Altman-Z 0.81
ROIC/WACC0.31
WACC9.09%
RMB.CA Yearly LT Debt VS Equity VS FCFRMB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 100K 200K 300K

2.3 Liquidity

RMB has a Current Ratio of 1.05. This is a normal value and indicates that RMB is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 0.94 indicates that RMB may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.94
RMB.CA Yearly Current Assets VS Current LiabilitesRMB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100K 200K 300K

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RMB.CA Yearly Revenue VS EstimatesRMB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 200K 400K 600K 800K
RMB.CA Yearly EPS VS EstimatesRMB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RMB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RMB.CA Price Earnings VS Forward Price EarningsRMB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 43.43
EV/EBITDA 45.09
RMB.CA Per share dataRMB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RMB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RUMBU HOLDINGS LTD

TSX-V:RMB (3/4/2025, 7:00:00 PM)

0.4

-0.1 (-20%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners61.02%
Ins Owner ChangeN/A
Market Cap5.11M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.15
P/FCF 43.43
P/OCF 36.78
P/B 6.99
P/tB N/A
EV/EBITDA 45.09
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.3%
OCF(TTM)0.01
OCFY2.72%
SpS0.19
BVpS0.06
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.23%
ROE -179.57%
ROCE 3.92%
ROIC 2.82%
ROICexc 2.98%
ROICexgc 4.86%
OM 8.02%
PM (TTM) N/A
GM 74.28%
FCFM 4.94%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 5.67
Debt/FCF 38.65
Debt/EBITDA 19.89
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 66.67%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.94
Altman-Z 0.81
F-ScoreN/A
WACC9.09%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.1%
OCF growth 3YN/A
OCF growth 5YN/A